Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
0.48%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NL-201 (IL-2 and IL-15 agonist) Details Solid tumor/s, Cancer | Failed Discontinued |